Neogenomics (NEO) Leases: 2011-2025
Historic Leases for Neogenomics (NEO) over the last 7 years, with Sep 2025 value amounting to $80.2 million.
- Neogenomics' Leases fell 1.59% to $80.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.2 million, marking a year-over-year decrease of 1.59%. This contributed to the annual value of $79.6 million for FY2024, which is 13.28% down from last year.
- Neogenomics' Leases amounted to $80.2 million in Q3 2025, which was down 3.28% from $82.9 million recorded in Q2 2025.
- Over the past 5 years, Neogenomics' Leases peaked at $102.3 million during Q3 2021, and registered a low of $50.9 million during Q1 2021.
- For the 3-year period, Neogenomics' Leases averaged around $85.1 million, with its median value being $83.7 million (2024).
- Its Leases has fluctuated over the past 5 years, first soared by 123.21% in 2021, then declined by 13.28% in 2024.
- Neogenomics' Leases (Quarterly) stood at $102.2 million in 2021, then fell by 5.96% to $96.1 million in 2022, then decreased by 4.52% to $91.8 million in 2023, then fell by 13.28% to $79.6 million in 2024, then fell by 1.59% to $80.2 million in 2025.
- Its Leases stands at $80.2 million for Q3 2025, versus $82.9 million for Q2 2025 and $77.8 million for Q1 2025.